Cite
2′, 4′-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg
MLA
Wen-Hui, Qi, et al. “2′, 4′-Dihydroxy-2,3-Dimethoxychalcone: A Pharmacological Inverse Agonist of RORγt Ameliorating Th17-Driven Inflammatory Diseases by Regulating Th17/Treg.” International Immunopharmacology, vol. 108, July 2022, p. 108769. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eee74ebb10b58315f54c04544c357de1&authtype=sso&custid=ns315887.
APA
Wen-Hui, Q., Yan-Yan, Z., Kun, X., Dong-Xia, H., Fei, Z., Rui-Ning, W., Ming-Yue, B., Meng-Yuan, T., Ya-Na, Y., Xing, L., & Yuan, Z. (2022). 2′, 4′-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg. International Immunopharmacology, 108, 108769.
Chicago
Wen-Hui, Qi, Zhang Yan-Yan, Xing Kun, Hao Dong-Xia, Zhang Fei, Wang Rui-Ning, Bao Ming-Yue, et al. 2022. “2′, 4′-Dihydroxy-2,3-Dimethoxychalcone: A Pharmacological Inverse Agonist of RORγt Ameliorating Th17-Driven Inflammatory Diseases by Regulating Th17/Treg.” International Immunopharmacology 108 (July): 108769. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eee74ebb10b58315f54c04544c357de1&authtype=sso&custid=ns315887.